Brief: Gilead Extends Tender Offer To Acquire Arcellx
01/04/2026 22:12
April 1 (Reuters) - Gilead Sciences Inc GILD.O: GILEAD EXTENDS TENDER OFFER TO ACQUIRE ARCELLX GILEAD - OFFER PRICE $115 PER SHARE PLUS $5 CVR PAYABLE MARCH 31, 2030, IF SALES MILESTONE MET GILEAD - TENDER OFFER EXPIRATION EXTENDED TO 5:00 P.M. ET ON APRIL 24, 2026 Source text: ID:nBw6cLjpBa Further company coverage: GILD.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Arcellx
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 02:18 PM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Gilead Extends Tender Offer To Acquire Arcellx
U.S. RESEARCH ROUNDUP-Arcellx, Costar Group, Magnite